Cargando…

Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy

To evaluate the predictive accuracy of the %p2PSA and prostate health index (PHI) in predicting aggressive pathological outcomes in patients with prostate cancer (PCa) undergoing radical prostatectomy (RP), we enrolled 91 patients with organ-confined PCa who were treated with robot-assisted RP. p2PS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yung-Ting, Huang, Chao-Yuan, Chen, Chung-Hsin, Chiu, Shih-Ting, Hong, Jian-Hua, Pu, Yeong-Shiau, Liu, Shih-Ping, Lu, Yu-Chuan, Chang, Yi-Kai, Chang, Hong-Chiang, Huang, Kuo-How, Lee, Yuan-Ju, Chow, Po-Ming, Chiang, I-Ni, Hung, Shih-Chun, Chiang, Chih-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972898/ https://www.ncbi.nlm.nih.gov/pubmed/31964956 http://dx.doi.org/10.1038/s41598-020-57618-2

Ejemplares similares

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience
por: Chiang, Bing-Juin, et al.
Publicado: (2013)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
por: Tseng, Chi-Shin, et al.
Publicado: (2021)

Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
por: Lu, Yu-Cheng, et al.
Publicado: (2022)

Predictive Clinical Indicators of Biochemical Progression in Advanced Prostate Cancer Patients Receiving Leuplin Depot as Androgen Deprivation Therapy
por: Chen, Chien-Hua, et al.
Publicado: (2014)

Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
por: Huang, Wei-Lun, et al.
Publicado: (2020)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Oncologic Outcomes of Asian Men with Clinically Localized Prostate Cancer after Extraperitoneal Laparoscopic Radical Prostatectomy: A Single-Institution Experience
por: Tai, Huai-Ching, et al.
Publicado: (2011)

Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer
por: Shih, Hung-Jen, et al.
Publicado: (2021)

Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle
por: Tseng, Chi-Shin, et al.
Publicado: (2017)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis
por: Lu, Yu-Chuan, et al.
Publicado: (2014)

Preoperative nutritional evaluation of prostate cancer patients undergoing laparoscopic radical prostatectomy
por: Shu, Wang, et al.
Publicado: (2022)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy
por: Park, Junsoo, et al.
Publicado: (2010)

The impact of primary location and age at orchiopexy on testicular atrophy for congenital undescended testis
por: Tseng, Chi-Shin, et al.
Publicado: (2019)

Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Comparisons of oncological and functional outcomes among radical retropubic prostatectomy, high dose rate brachytherapy, cryoablation and high-intensity focused ultrasound for localized prostate cancer
por: Chiang, Po Hui, et al.
Publicado: (2016)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells
por: Huang, Kuo-How, et al.
Publicado: (2013)

Clinical Significance of Preoperative Assessment of Intravesical Prostatic Protrusion in Radical Prostatectomy
por: Tang, Jie, et al.
Publicado: (2023)

Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up
por: Yang, Teng-Kai, et al.
Publicado: (2016)

Comparative Outcomes of Robotic Radical Prostatectomy in Patients with Locally Advanced Prostate Cancer
por: Li, Po-I, et al.
Publicado: (2022)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction
por: Hsu, Fu-Shun, et al.
Publicado: (2019)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Author Correction: Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction
por: Hsu, Fu-Shun, et al.
Publicado: (2019)

Recommended Initial Antimicrobial Therapy for Emphysematous Pyelonephritis: 51 Cases and 14-Year-Experience of a Tertiary Referral Center
por: Lu, Yu-Chuan, et al.
Publicado: (2016)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

IVIM Parameters on MRI Could Predict ISUP Risk Groups of Prostate Cancers on Radical Prostatectomy
por: Chang, Chun-Bi, et al.
Publicado: (2021)

Prostate specific antigen (PSA) persistence 6 weeks after radical prostatectomy and pelvic lymph node dissection as predictive factor of radiographic progression in node-positive prostate cancer patients
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study
por: Chiang, I-Ni, et al.
Publicado: (2017)

Preoperative Erythropoietin Administration in Patients With Prostate Cancer Undergoing Radical Prostatectomy Without Transfusion
por: Lee, Byung Woo, et al.
Publicado: (2014)

Role of preoperative patient education among prostate cancer patients treated by radical prostatectomy
por: Jurys, Tomasz, et al.
Publicado: (2022)

Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer
por: Huang, Chao-Yuan, et al.
Publicado: (2015)

Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
por: Grasso, Marco, et al.
Publicado: (2004)

Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
por: Novak, Vojtech, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jmvkej725h4c0hdbkhtro0fntu